We haven’t covered that many retractions in economics, and a 2012 paper found very few such retractions. Now, a new study based on a survey of economists tries to get a handle on how often economists commit scientific misconduct.
Here’s the abstract of “Scientific misbehavior in economics,” which appeared in Research Policy: Continue reading How often do economists commit misconduct?
The editors of PLoS ONE have issued an Expression of Concern (which seems likely to become a retraction) for a 2014 paper by a group of researchers in China who claim to have been led astray by a contractor hired to “edit the language” of the report.
The article, “Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein,” came from a group in the Department of Hematology at the First Affiliated Hospital at Xi’an Jiaotong University, and was led by Yuwang Tian, a pathologist at the General Hospital of Beijing Military Area of PLA.
Or at least that’s what the manuscript eventually said. According to the expression of concern, however, that’s not what it said initially: Continue reading Wayward “contractor” prompts expression of concern for PLoS ONE paper on cancer cells
A 2011 paper in Science has been subjected to an expression of concern and has led to an investigation by the Texas university where the work was done.
Here’s the expression of concern, signed by Science editor in chief Marcia McNutt (and paywalled): Continue reading Chemistry paper in Science earns expression of concern for unreliable data
A Boston doctor indicted on charges of Medicare fraud in 2007 has had a paper relating to the case retracted this month.
Abdul Razzaque Ahmed was considered something of a miracle worker by his patients, treating two rare and disfiguring skin conditions called pemphigoid and pemphigus vulgaris. He used more powerful medicines than the typical course of treatment, including a drug normally used to treat cancer.
The initial indictment stated that Ahmed mixed blood samples to falsely show a “dual diagnosis” of both diseases, and prove to Medicare that they required the more rigorous (and expensive) treatment. It also alleged that he profited massively from the government pay-outs. He was convicted of obstruction in 2007; the other charges were dropped when he agreed to forfeit assets worth $2.9 million.
Now, a 2001 paper by Ahmed, which claimed fifteen patients had a dual diagnosis, has been retracted because the samples were all mixed. Here is the retraction notice from Clinical Immunology: Continue reading Alleged Medicare cheat loses paper for data mix-up
Pro tip: If you’re going to write about stalking, it’s probably best if you don’t get too close to your material.
That’s a lesson a group of researchers in Italy was forced to learn the hard way. They lost their 2013 article in Medicine, Science and the Law for being too similar to a 2008 paper by different authors in another journal.
According to the abstract: Continue reading Don’t walk this way: Stalking paper halted for plagiarism
Alfredo Fusco, who is under criminal investigation in Italy for scientific fraud, has had two more papers retracted.
Both are in the Journal of Biological Chemistry (JBC). Here are the two studies: Continue reading Cancer researcher facing criminal inquiry up to six retractions
In September, we wrote about the retraction of a physics paper for “a pattern that was unphysical.”
The team, whose first author, R.K. Singhal refused to sign the notice, has had another paper retracted, this one in the Journal of Applied Physics. Here’s the notice for “Study of electronic structure and magnetization correlations in hydrogenated and vacuum annealed Ni doped ZnO:” Continue reading Physicists with retraction for a “pattern that was unphysical” lose another for manipulation
A highly controversial — and retracted — 2012 study by Gilles Seralini and colleagues of the effects of genetically modified maize and the Roundup herbicide on rats has been republished.
Retraction Watch readers may recall that the editor of Food and Chemical Toxicology decided to retract the heavily criticized paper because it was “inconclusive.” The editor, A. Wallace Hayes, claimed that this was consistent with Committee on Publication Ethics (COPE) guidelines, although we and many others disagreed.
Here’s the original abstract of the Food and Chemical Toxicology paper, which has been cited 55 times, according to Thomson Scientific’s Web of Knowledge: Continue reading Retracted Seralini GMO-rat study republished
A review of past publications by the Japanese research institution RIKEN has produced three corrections of articles by a molecular geneticist, Haruhiko Koseki, The Scientist is reporting. The articles had appeared in Molecular and Cellular Biology between 2005 and 2010.
The review was triggered by the scandal involving Haruko Obokata, a former RIKEN scientist whose work on STAP stem cells has come under scrutiny. However, RIKEN officials said the corrections are unrelated to the Obokata case. Obokata has reportedly agreed to retract two of her articles in Nature. (RIKEN has released an English-language translation of its response to Obokata’s appeal against charges of research misconduct.)
According to The Scientist, Koseki was a member of a committee charged with investigating Obokata’s STAP results: Continue reading RIKEN inquiry prompted by STAP stem cell controversy generates three corrections
A group of cancer genetics researchers in Italy and the U.S. has retracted three papers in the Journal of Biological Chemistry (JBC) after it became aware they had duplicated some bands in their figures.
Here are the three papers: Continue reading Cancer genetics group retracts three papers for “inappropriate presentation of data”